Annual report pursuant to Section 13 and 15(d)

Note 7 - Investment in Unconsolidated Affiliates (Details)

v3.20.4
Note 7 - Investment in Unconsolidated Affiliates (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Total equity method investments $ 373 $ 535
Venator Materials PLC [Member]    
Total equity method investments [1] 0 200
BASF Huntsman Shanghai Isocyanate Investment BV [Member]    
Total equity method investments [2] 111 112
Nanjing Jinling Huntsman New Material Co., Ltd. [Member]    
Total equity method investments 229 196
Jurong Ningwu New Material Development Co., Ltd. [Member]    
Total equity method investments $ 33 $ 27
[1] On December 23, 2020, we completed the sale of approximately 42.4 million ordinary shares of Venator, and we no longer account for our current remaining ownership interest in Venator as an equity method investment, but rather as an investment in equity securities that are marked to fair value with changes in fair value reported in earnings. As of December 31, 2020, our investment in Venator was $32 million and was included in other noncurrent assets on our consolidated balance sheets.
[2] We own 50% of BASF Huntsman Shanghai Isocyanate Investment BV. BASF Huntsman Shanghai Isocyanate Investment BV owns a 70% interest in SLIC, thus giving us an indirect 35% interest in SLIC.